Status:
WITHDRAWN
Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa
Lead Sponsor:
Center for Research on Filariasis and Other Tropical Diseases, Cameroon
Conditions:
Onchocerciasis
Loiasis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study aims at evaluating the diagnosis performances of the LTS-2 DEC patch for onchocerciasis compared to the gold standard which are the skin snips. This study will be conducted in Cameroon in t...
Eligibility Criteria
Inclusion
- All voluntary adults
Exclusion
- General acute infection (temperature ≥ 38,5°C)
- Impaired general condition
- Ivermectin taken in the 6 last months
- Known allergies to one of the component of the patch
- Dermatological acute infection (bacterial, atopic, prurigo, or zona)
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04035174
Start Date
September 1 2022
End Date
March 30 2023
Last Update
March 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de Recherche sur les filarioses et autres maladies tropicales (CRFilMT)
Yaoundé, Cameroon